Peppas N.A. / Budd / R.I. Mahato A.S. / M.N.V. / Acta Pharm / J. Pharm / L. Thoma D.D. / N. Venkatesan S.P. / /
Country
India / /
Event
FDA Phase / /
Facility
pharmacy Maisammaguda / /
IndustryTerm
ocular devices / drug delivery devices / injection site / drug carrier matrices / chemical and enzymatic degradation / surfactant systems / colloidal drug delivery systems / oral peptide drug delivery systems / stable mixtures containing water oil / multicomponent systems / treatment of diabetes / potential oral drug delivery systems / carrier matrices / threedimensional network / drug carrier / ocular device / pharmaceutical and biomedical applications / micellar systems / drug delivery systems / gliadin nanoparticulate systems / graft copolymer networks / chemical degradation / aqueous media / aqueous solutions / Diabetes Care / materisive particulate systems / potential oral delivery systems / oral drug delivery systems / swollen polyelectolyte networks / pHresponsive copolymer networks / /
drug carrier / drug delivery system / nanocapsules / self administration / drug delivery systems / insulin therapy / insulin injections / insulin delivery / /
Organization
T. S. RAJESWARI ABSTRACT T.S.RAJESWARI Department of Pharmaceutics Malla / US Federal Reserve / Insulin administration / /
Person
Jaleh Varshosaz / Wen F. Xua / Jia Chen / Mounir S. Mesiha / Amit kumar / Celinda Gourd / Marcel Dekker / Abbas Pardakhty / Ravi Kumar / Nat / Gloria Olivier / A. Blair / Wei Hsu / John McLeod / Babatunde Fasipe / Lee / V / Emily Bubbers / Michael U. Adikwu / Danielle Abramson / Edith Mathiowitz / Charles Best / Anthony A. Attama / Frederick Banting / Kiran Sonaje / Stacia Furtado / Roxanne Burrill / Larry C. Okpaku / V. Rama Prasad / Harpal Singh / Hassan I Al-Shora / /
Journal of Applied Pharmaceutical Science[removed]); 2011: [removed]ISSN: [removed]Received on: [removed]Revised on: [removed]Accepted on: [removed]